BUFFERED ASPIRIN and OSTEOPOROSIS

68 reports of this reaction

1.5% of all BUFFERED ASPIRIN reports

#11 most reported adverse reaction

Overview

OSTEOPOROSIS is the #11 most commonly reported adverse reaction for BUFFERED ASPIRIN, manufactured by Lil' Drug Store Products, Inc.. There are 68 FDA adverse event reports linking BUFFERED ASPIRIN to OSTEOPOROSIS. This represents approximately 1.5% of all 4,540 adverse event reports for this drug.

Patients taking BUFFERED ASPIRIN who experience osteoporosis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OSTEOPOROSIS68 of 4,540 reports

OSTEOPOROSIS is a less commonly reported adverse event for BUFFERED ASPIRIN, but still significant enough to appear in the safety profile.

Other Side Effects of BUFFERED ASPIRIN

In addition to osteoporosis, the following adverse reactions have been reported for BUFFERED ASPIRIN:

CHRONIC KIDNEY DISEASE — 721 reports
ACUTE KIDNEY INJURY — 439 reports
RENAL FAILURE — 395 reports
END STAGE RENAL DISEASE — 256 reports
RENAL INJURY — 179 reports
GASTROOESOPHAGEAL REFLUX DISEASE — 117 reports
NEPHROGENIC ANAEMIA — 117 reports
REBOUND ACID HYPERSECRETION — 78 reports
DEPRESSION — 72 reports
NAUSEA — 72 reports

Other Drugs Associated with OSTEOPOROSIS

The following drugs have also been linked to osteoporosis in FDA adverse event reports:

ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE ATAZANAVIR BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE BISMUTH SUBSALICYLATE CALCIUM CARBONATE, MAGNESIUM HYDROXIDE DARUNAVIR DOLUTEGRAVIR SODIUM ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE AND TENOFOVIR ALAFENAMIDE EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE LAMIVUDINE AND ZIDOVUDINE LOPINAVIR AND RITONAVIR RALTEGRAVIR RILPIVIRINE HYDROCHLORIDE RITONAVIR TENOFOVIR DISOPROXIL FUMARATE TENOFOVIR DISOPROXIL FUMARATE TABLETS

Frequently Asked Questions

Does BUFFERED ASPIRIN cause OSTEOPOROSIS?

OSTEOPOROSIS has been reported as an adverse event in 68 FDA reports for BUFFERED ASPIRIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OSTEOPOROSIS with BUFFERED ASPIRIN?

OSTEOPOROSIS accounts for approximately 1.5% of all adverse event reports for BUFFERED ASPIRIN, making it a notable side effect.

What should I do if I experience OSTEOPOROSIS while taking BUFFERED ASPIRIN?

If you experience osteoporosis while taking BUFFERED ASPIRIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

BUFFERED ASPIRIN Full Profile All Drugs Causing OSTEOPOROSIS Lil' Drug Store Products, Inc. Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.